Assessing human health response in life cycle assessment using ED10s and DALYs: Part 1 - Cancer effects

Risk Analysis

Volumn 22, Issue 5, 2002, Pages 931-946

  Crettaz, Pierre ^a,b   Pennington, David ^a   Rhomberg, Lorenz ^c   Brand, Kevin ^d   Jolliet, Olivier ^a  

^a EPFL   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^c GRADIENT   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cancer; Carcinogenic slope factor; DALY; Dose response curve; Human health; Life cycle impact assessment (LCA); Toxicity characterization factors

Indexed keywords

BIOASSAY; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PROTECTION; LIFE CYCLE; POPULATION STATISTICS; RAW MATERIALS; TOXICITY; TUMORS;

RESIDUAL RISKS;

HEALTH RISKS;

ENVIRONMENTAL CHEMICAL;

ASSESSMENT METHOD; CANCER; HEALTH RISK; LIFE CYCLE; RISK ASSESSMENT; TOXICITY;

BIOASSAY; CANCER; CANCER RISK; CHEMICAL CARCINOGENESIS; DATA BASE; DISABILITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL MONITORING; HEALTH HAZARD; HUMAN; LD 50; LIFE CYCLE; POLLUTION; PREDICTION; REVIEW; RISK ASSESSMENT;

CARCINOGENS, ENVIRONMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; ENVIRONMENTAL HEALTH; ENVIRONMENTAL POLLUTANTS; HUMANS; LETHAL DOSE 50; LIFE TABLES; NEOPLASMS; NONLINEAR DYNAMICS; RISK ASSESSMENT; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 0036773412     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/1539-6924.00262     Document Type: Review

References (53)

1. Armitage, P. (1985). Multistage models of carcinogenesis, Environmental Health Perspectives, 63, 195-201.
2. Baird, S. J. S., Cohen, J. T., Graham, J. D., Shlyakhter, A. I., & Evans, J. S. (1996). Noncancer risk assessment: A probabilistic alternative to current practice, Human and Ecological Risk Assessment, 2(1), 79-102.
3. Bare, J. C., Hofstetter, P., Pennington, D. W., & Udo de Haes, H. A. (2000). Life cycle impact assessment workshop summary - Midpoints versus endpoints: The sacrifices and benefits. International Journal of LCA, 5(6), 319-326.
4. Barnthouse, L., Fava, J., Humphreys, K., Hunt, R., Laibson, L., Noesen, S., Owens, J., Todd, J., Vigon, B., Weitz, K., & Young, J. (1997). Life-Cycle Assessment: The State-of-the-Art. Pensacola, FL: SETAC Press.
5. Beck, B., Rudel, R., & Calabrese, E. (1994). The use of toxicology on the regulatory process. In W. A. Hayes (Ed.), Principles and Methods of Toxicology. New York: Raven Press.
6. Bennett, D. H., Margni, M. D., McKone, T. E., & Jolliet, O. (This issue). Intake fraction for multimedia pollutants: A tool for life cycle analysis and comparative risk assessment. Risk Analysis.
7. Burke, T. A., Doull, J., McKone, T., Paustenbach, D., Scheuplein, R., Udo de Haes, H. A., & Young, J. S. (1996). Human health impact assessment. In Life Cycle Assessment: Analysis by an Expert Panel. Washington, DC: ILSI Health and Environmental Sciences Institute.
8. Chen, J. J., & Kodell, R. L. (1989). Quantitative risk assessment for tetralogical effects. Journal of the American Statistical Association, 84, 966-971.
9. Consoli, F., Allen, D., Boustead, I., de Oude, N., Fava, J., Franklin, W., Parrish, R., Perriman, R., Postlethwaite, D., Quay, B., Seguin, J., & Vigon, B. (Eds.). (1993). Guidelines for Life Cycle Assessments: A "Code of Practice." Pensacola, FL: SETAC Press.
10. Crettaz, P. (2000). From Toxic Emissions to Human Health Impact: A Generic Model for Life Cycle Impact Assessment. Dissertation. Lausanne: Swiss Federal Institute of Technology, EPFL.
11. Crouch, E. (1985). MSTAGE (Version 1.1). Software. 44 Radcliffe Road, Somerville, MA 02145, USA.
12. Crouch, E. A. C., Wilson, R., & Zeise, L. (1987). Tautology or not tautology. Journal of Toxicology and Environmental Health, 20, 1.
13. Crump, K. S. (1984). A new method for determining allowable daily intakes. Fundamental and Applied Toxicology, 4, 854-871.
14. Eaton, D., & Klaassen, C. (1996). Principles of toxicology. In D. Curtis (Ed.), Casarett & Doull's Toxicology, the Basic Science of Poisons. New York: McGraw-Hill.
15. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). (1995). Assessment Factors in Human Health Risk Assessment. Technical Report No. 68. Brussels.
16. Evans, J., Wolff, S., Phonboon, K., Levy, J., & Smith, K. (In press). Exposure Efficiency: An Idea Whose Time has Come? Chemosphere.
17. Fava, J. A., Denison, R., Jones, B., Curran, M. A., Vigon, B. W., Selke, S., & Barnum, J. (Eds.). (1991). A Technical Framework for Life Cycle Assessments. Pensacola, FL: SETAC Press.
18. Gaylor,D. W., & Gold, L. S. (1995). Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays. Regulatory Toxicology and Pharmacology, 22, 57-63.
19. Guess, H., Crump, K., & Peto, R. (1977). Uncertainty estimates for low-dose-rate extrapolation of animal carcinogenicity data. Cancer Research, 37, 3475-3483.
20. Goedkoop, M., & Spriensma, R. (1999). The Eco-Indicator 99; A Damage Oriented Method for Life Cycle Impact Assessment. The Netherlands: Pré Consultants.
21. Gold, L. S., & Zeiger, E. (1997). Handbook of Carcinogenic Potency and Genotoxicity Databases. Boca Raton, CRC Press.
22. Gray, G., Taylor, A., & Evans, J. (1991). Relationship of the Upper Confidence Limit and the Maximum Likelihood Estimate of the Low Dose Potency for IRIS Carcinogens. Boston, MA: Harvard University-HSPH.
23. Guinée, J. B., Heijungs, R., Van Oers, L., Van de Meent, D., Vermeire, T., & Rikken, M. (1996). LCA Impact Assessment of Toxic Releases: Generic Modelling of Fate, Exposure and Effect for Ecosystems and Human Beings with Data for About 100 Chemicals. Leiden, the Netherlands: Centre of Environmental Science, Leiden University (CML); Bilthoven, the Netherlands: National Institute of Public Health and Environmental Protection (RIVM).
24. Hammitt, J. K. (This issue). WTP versus QALYs. Risk Analysis.
25. Hertwich, E. (1999). Toxic Equivalency: Addressing Human Health Effects in Life Cycle Impact Assessment. Dissertation. Berkeley, CA: University of California.
26. Hofstetter, P. (1998). Perspectives in Life Cycle Impact Assessment, a Structured Approach to Combine Models of the Technosphere, Ecosphere and Valuesphere. Boston: Kluwer Academic Publishers.
27. Hofstetter, P., & Hammitt, J. K. (This issue). Selecting human health metrics for environmental decision support tools. Risk Analysis.
28. Huijbregts, M. A. (1999). Priority assessment of toxic substances in LCA, application of the uniform system for the evaluation of substances 2.0. Amsterdam: University of Amsterdam. Available at http://www.leidenuniv.nl.
29. IRIS. (1998). US EPA's Integrated Risk Information System. Available at http://www.epa.gov.
30. Jager, D. T., & Visser, C. J. M. (1994). Uniform System for the Evaluation of Substances (USES) (Version 1.0). Software. RIVM, VROM, WVC., Distribution No. 11144/150.
31. Jolliet, O., & Crettaz, P. (1997). Critical Surface-Time 95, a Life Cycle Assessment Methodology Including Fate and Exposure. Switzerland: EPFL.
32. Kodell, R., & Park, C. (1995). Linear extrapolation in cancer risk assessment. In S. Olin, W. Farland, C. Park, L. Rhomberg, R. Scheuplein, T. Starr, & J. Wilson (Eds.), Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives. Washington, DC: ILSI Press.
33. Krewitt, W., Pennington, D. W., Olsen, S. I., Crettaz, P., & Jolliet, O. (2002). Indicators for Human Toxicity in Life Cycle Impact Assessment. In Udo De Haes et al. (Eds.), Towards best available practice in life cycle impact assessment. Brussels, Belgium: SETAC Europe Press.
34. Krewski, D., Gaylor, D. W., Soms, A. P., & Szyszkowicz, M. (1993). An overview of the report: Correlation between carcinogenic potency and the maximum tolerated dose: Implications for risk assessment. Risk Analysis, 13(4), 383-398.
35. Krewski, D., Murdoch, D., & Withey, J. R. (1989). Recent developments in carcinogenic risk assessment. Health Physics, 57(Supp. 1), 313-325.
36. Metzger, B., Crouch, E., & Wilson, R. (1989). On the relationship between carcinogenicity and acute toxicity. Risk Analysis, 9(2), 169-177.
37. Murray, C., & Lopez, A. (1996). The global burden of disease, a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. In Global Burden of Disease and Injury Series (Vols. 1 & 2). Cambridge, MA: Harvard School of Public Health, World Health Organization, and World Bank.
38. Nendza, M. (1998). Structure-Activity Relationships in Environmental Sciences. United Kingdom: Chapman & Hall.
39. Olin, S., Farland, W., Park, C., Rhomberg, L., Scheuplein, R., Starr, T., & Wilson, J. (1995). Low Dose Extrapolation of Cancer Risks: Issues and Perspectives. Washington, DC: International Life Science Institute Press.
40. Owens, J. W. (2002). Chemical toxicity indicators for human health: Case study for classification of chronic non-cancer chemical hazards in life cycle assessment. Environmental Chemistry and Toxicology, 21(1), 207-225.
41. 10s and DALYs: Part 2 - Noncancer effects. Risk Analysis.
42. Pennington, D. W., & Jolliet, O. (2001). Time-integrated risks and potential consequences: The fate and exposure modelling community's role in life cycle assessment (LCA). Society of Environmental Toxicology and Chemistry (SETAC) Globe Newsletter, September/October, 44-48.
43. Reith, J. P., & Starr, T. B. (1989). Chronic bioassays: Relevance to quantitative risk assessment of carcinogens. Regulatory Toxicology and Pharmacology, 10, 160-173.
44. RTECS. (1998). Registry of Toxic Effects of Chemical Substances. Washington, DC: U.S. National Institute for Occupational Safety and Health.
45. Shoaf, C., Caldwell-Kenkel, J., & Scott, C. S. (1995). In S. D. Lee and T. Schneider (Eds.), Comparative Risk Analysis and Priority Setting for Air Pollution Issues. Air & Waste Management Association, Pittsburgh, Pennsylvania.
46. Slob, W. (1999). Thresholds in toxicology and risk assessment. International Journal of Toxicology, 18, 259-268.
47. Udo de Haes, H. A. (Ed.). (1996). Towards a Methodology for Life Cycle Impact Assessment. Brussels, Belgium: SETAC Europe Press.
48. U.S. EPA. (1986). Guidelines for carcinogen risk assessment. Federal Register, 51(185), 33992-34003.
49. U.S. EPA. (1996). Proposed Guidelines for Carcinogen Risk Assessment. Washington, DC: U.S. EPA.
50. U.S. EPA. (1999). Benchmark Dose Software (Beta Version 1.1b). U.S. EPA. Available at http://www.epa.gov/ncea/bmds.htm.
51. Vermeire, T. G., Stevenson, H., Pieters, M. N., Rennen, M., Slob, W., & Hakkert, B. C. (1998). Assessment Factors for Human Health Risk Assessment: A discussion paper. Bilthoven, the Netherlands: National Institute of Public Health and the Environment and Netherlands Organization for Applied Scientific Research.
52. Zeise, L., Wilson, R., & Crouch, E. (1984). Use of acute toxicity to estimate carcinogenic risk. Risk Analysis, 4(3), 187-199.
53. Zeise, L., Crouch, E., & Wilson, R. (1986). A possible relationship between toxicity and carcinogenicity. Journal of the American College of Toxicity, 5, 137-151.